腹主动脉瘤腔内修复术后瘤囊明显回缩后延长随访间隔安全且适当
回顾性分析2008至2011年本院540例择期肾下型EVAR患者,比较瘤囊回缩至≤40 mm与未回缩者的结局。瘤囊回缩至≤40 mm与更高的免于再干预或破裂率相关(log-rank P < .01),控制死亡竞争风险后仍显著(P < .01)。作者认为瘤囊回缩至40 mm后将随访间隔延长至3年风险极小。
要点
- 540例EVAR患者中166例(31%)瘤囊回缩至≤40 mm,仅1例需再干预,无破裂。
- 瘤囊回缩至≤40 mm与免于再干预或破裂改善相关(log-rank P < .01)。
- 166例中仅8例(5%)瘤囊再扩张至>45 mm,其中6例发生在回缩至≤40 mm后至少3年。
核心结论
- 长期随访中,EVAR术后瘤囊最小直径回缩至≤40 mm的患者再干预、破裂或瘤囊再扩张发生率极低。
- 多数瘤囊再扩张发生在达到≤40 mm阈值后至少3年,且未导致临床事件。
- 作者认为瘤囊回缩至40 mm后将随访间隔延长至3年,动脉瘤相关并发症风险极小。
研究设计与样本
- 回顾性分析2008至2011年本院择期肾下型EVAR患者540例(年龄75.1 ± 8.2岁,82.0%男性)。
- 术前腹主动脉瘤平均直径55.2 ± 11.5 mm,术后中位随访5.3年(四分位距1.4-8.7年)。
- 以术后1个月CT血管造影基线直径对比超声或CT血管造影小轴测量直径,比较瘤囊回缩至预设最小直径阈值者与未回缩者。
主要发现
- 随访期间64例接受再干预,4例发生破裂。
- 瘤囊回缩至≤40 mm与免于再干预或破裂改善相关(log-rank P < .01),控制死亡竞争风险后仍显著(P < .01)。
- 376例(70%)瘤囊持续>40 mm,其中63例接受99次再干预;166例(31%)瘤囊回缩至≤40 mm,仅1例需再干预,无破裂。
- 回缩至≤40 mm的平均时间为2.3 ± 1.9年;仅8例(5%)瘤囊再扩张至>45 mm,其中6例发生在回缩至≤40 mm后至少3年。
临床怎么用
- 作者认为,瘤囊回缩至40 mm后将随访间隔延长至3年,动脉瘤相关并发症风险极小。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Abdominal aortic aneurysm (AAA) shrinkage after endovascular aortic aneurysm repair (EVAR) is a surrogate marker for successful exclusion. Our study characterized aneurysm sac remodeling after EVAR to identify a pattern that may be associated with benign AAA behavior and would safely allow a less rigorous follow-up regimen after EVAR. METHODS: Elective infrarenal EVARs performed between 2008 and 2011 at our institution were retrospectively reviewed. AAA sac diameters using the minor axis measurement from ultrasound imaging or computer tomography angiogram imaging were compared with the baseline diameter from the 1-month postoperative computer tomography angiogram. The primary outcome was a composite of freedom from postoperative reintervention or rupture. We compared those with AAA sacs who regressed to predefined minimum diameter thresholds with those who did not. Outcomes were plotted with Kaplan-Meier curves and compared using log-rank testing and Fine-Gray regression using death as a competing risk, clustered on graft type. For patients whose AAA reached the minimum sac diameter, landmark analysis evaluated ongoing size changes including further regression and sac re-expansion. RESULTS: A total of 540 patients (aged 75.1 ± 8.2 years; 82.0% male) underwent EVAR with an average preoperative AAA size of 55.2 ± 11.5 mm. The median postoperative follow-up was 5.3 years (interquartile range, 1.4-8.7 years) during which 64 patients underwent reintervention and 4 ruptured. AAA sac regression to ≤40 mm in diameter was associated with improved freedom from reintervention or rupture overall (log-rank, P < .01), which was maintained after controlling for the competing risk of death (P < .01). In 376 patients (70%) whose aneurysm sac remained >40 mm, 99 reinterventions were performed on 63 patients. Of 166 (31%) patients whose sac regressed to ≤40 mm, only 1 patient required a reintervention, and no one ruptured. The mean time to a diameter of ≤40 mm was 2.3 ± 1.9 years. Only eight patients (5%) developed sac re-expansion to >45 mm; all but two occurred at least 3 years after initially regressing to ≤40 mm. CONCLUSIONS: In long-term follow-up, patients whose minimum AAA sac diameter regressed ≤40 mm after EVAR experienced a very low rate of reintervention, rupture, or sac re-expansion. Most sac re-expansion occurred at least 3 years after reaching this threshold and did not result in clinical events. Increasing follow-up frequency up to 3-year intervals once the AAA sac regresses to 40 mm would carry minimal risk of aneurysm-related morbidity.
引用
- Andraska EA, Phillips AR, Reitz KM, et al. Longer follow-up intervals following endovascular aortic aneurysm repair are safe and appropriate after marked aneurysm sac regression. J Vasc Surg. 2022. PMID: 35093463. doi:10.1016/j.jvs.2022.01.079
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。